Dr. Tothova is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
450 Brookline Avenue, D0259
Boston, MA 02115Phone+1 617-632-2933Fax+1 617-632-2933
Education & Training
- Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2011 - 2014
- Brigham and Women's HospitalResidency, Internal Medicine, 2009 - 2011
- Harvard Medical SchoolClass of 2009
Certifications & Licensure
- MA State Medical License 2015 - 2026
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Cohesin mutations and chromatin changes in cancer.Ariel D Swett, Zuzana Tothova
International Journal of Cancer. 2025-03-10 - 5 citationsSteering research on mRNA splicing in cancer towards clinical translation.Olga Anczukow, Frédéric H-T Allain, Brittany L Angarola, Douglas L Black, Angela N Brooks
Nature Reviews. Cancer. 2024-12-01 - 3 citationsSubunit-specific analysis of cohesin-mutant myeloid malignancies reveals distinct ontogeny and outcomes.Johann-Christoph Jann, Christopher B Hergott, Marisa Winkler, Yiwen Liu, Benjamin Braun
Leukemia. 2024-09-01
Press Mentions
- A Community of ResearchersDecember 18th, 2020
- Dana-Farber Receives $5 Million Gift to Create the Edward P. Evans Center for MDSSeptember 16th, 2019
- Dana-Farber Physician Zuzana Tothova Receives Doris Duke Foundation Paragon Award for Research ExcellenceNovember 24th, 2023
Grant Support
- Molecular mechanisms of splicing dependency in cohesin-mutant myelodysplasiaDANA-FARBER CANCER INST2023–2028
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: